Much of America has turned a blind eye to how medical institutions in European nations have shifted away from transgender procedures, according to doctors who are critical of the U.S. model.
Dr. Julia Mason, a member of the American Academy of Pediatrics (AAP), told The Epoch Times that the push in the United States for transgender medical interventions on minors is “primarily political” and linked to profit-making.
“The United States is becoming more of an outlier every day,” Mason said. “Every country that has taken a serious look at the evidence has concluded that medical transition of children is experimental, and the evidence doesn’t support doing it.”
In recent years, leaders in the U.S. health care industry such as the AAP have ramped up the promotion and use of puberty blockers and cross-sex hormones and have even recommended gender transition surgeries for children.
But as President Joe Biden and blue states harden their political resolve to support what they call “gender-affirming” procedures as the only approach to treatment for the recent surge in gender dysphoria, red states are pushing back with legislation to protect minors from what many Americans see as child abuse.
The Wall Street Journal reported in May that 16 states restricted transgender medical interventions for minors this year, while 16 others introduced similar legislation.
In his remarks at the White House on June 8, Biden condemned attempts to ban sex-change surgeries and transgender medical interventions on children, calling such proposed legislation “cruel and callous.”
In contrast, European medical institutions in the United Kingdom, Sweden, Finland, Norway, and France are growing increasingly skeptical of what supporters call the “gender-affirmation model,” citing a dearth of evidence that the benefits of such medical interventions for minors are worth the risks.
Britain’s National Health Service announced on June 9 it would ban the use of puberty blockers on children, except in clinical trials. Meanwhile, an independent and systematic Cass Review in 2022 led to the closure of the Tavistock Clinic in London….